Osteoporosis Drugs Double Risk of Esophageal Cancer!
Boniva, Actonel, Reclast, Fosamax: Danger: Cancer!
The most popular osteoporosis drugs on the market include: Actonel, Boniva, Reclast and Fosamax. These drugs are known as bisphosphonates, and they are prescribed to women to prevent bone fractures. (I'm sure you've seen that famous actress on TV who is the spokesperson for one of the aforementioned drugs.)
A recent study, however, found that those on bisphosphonates for five years or more doubled their risk of esophageal cancer!
Bisphosphonates and Cancer Risk!
The study was published in the British Medical Journal and conducted by Jane Green, Oxford University's Cancer Epidemiology Unit.
The research was conducted between 1995-2005, following men and women over age 40, who had contracted cancer, either esophageal, colorectal, or stomach.
They found that those who had been on bisphosphonates for five years or more had double the risk of contracting esophageal cancer! There was no link to stomach or bowel cancer.
Madam Aphrodite™ Speaks...
If you are on any of the drugs prescribed for osteoporosis, tell your doctor immediately if you experience difficulty swallowing, and/or throat and chest discomfort, or digestive upset. This is important! Your doctor is the one to best evaluate if you need to discontinue the drug.
As Green notes, "These are very commonly prescribed drugs and we don't have enough information about the long-term risks and benefits."
NOTE: I would think that these drugs should be tried and tested as to their long-term risks and benefits, BEFORE they're prescribed to the public!
CAUTION: The information included herein is for educational purposes only. It is not intended nor implied to be a substitute for professional medical advice. The reader should always consult his or her healthcare provider to determine the appropriateness of the information for their own situation or if they have any questions regarding a medical condition or treatment plan.